Legal Shield for Purdue Pharma Owners is at Heart of Appeals - San Francisco Chronicle -BoardProspects

Legal Shield for Purdue Pharma Owners is at Heart of Appeals

San Francisco Chronicle Sep 6 2021 BoardNews

The end of the Purdue Pharma bankruptcy case has left a bitter taste for those who wanted to see more accountability for members of the Sackler family. The Sacklers will give up ownership of the company, go out of the international opioid business and pay $4.5 billion in cash and charitable assets under the settlement...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
- Wells Fargo's Board Should Take Some Blame for Fiasco also published in San Francisco Chronicle
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- New Wells Fargo CEO Defends Board That Got it Into This Mess also published in San Francisco Chronicle
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- Germany's Corporate Governance Problem also categorized in BoardNews
- Have the Swiss Gone Cuckoo? also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Quotes
1. They get to retain literally billions of dollars they took out of Purdue Pharma while it was causing addiction and death all across our country and all across the world.
2. I wish the plan had provided for more
3. If they continue to appeal, if they win, what do they get?
Topics Mentioned
Authors
- Geoff Mulvihill